Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Alterity Therapeutics Ltd. ( (AU:ATH) ) is now available.
Alterity Therapeutics Limited announced the quotation of a new class of options on the Australian Securities Exchange, with an exercise price of $0.028 and an expiration date in February 2027. This move signifies a strategic financial decision aimed at enhancing the company’s capital structure, potentially impacting its market positioning and providing stakeholders with new investment opportunities.
More about Alterity Therapeutics Ltd.
Alterity Therapeutics Limited operates in the biotechnology industry, focusing on developing therapies for neurodegenerative diseases. The company is primarily engaged in creating treatments that target the underlying causes of these conditions, with a market focus on innovative medical solutions.
Average Trading Volume: 1,000
Technical Sentiment Signal: Buy
Current Market Cap: $40.82M
Find detailed analytics on ATH stock on TipRanks’ Stock Analysis page.